Sensus Healthcare, Inc. is a medical device company. Co. is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. Co. uses a low-energy X-ray technology known as superficial radiation therapy (SRT). Co. incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. We show 35 historical shares outstanding datapoints in our SRTS shares outstanding history coverage, used to compute SRTS market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing SRTS market cap history over the course of time is important for investors
interested in comparing SRTS's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of SRTS versus a peer is one thing; comparing
SRTS market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like SRTS can fluctuate over the course of history.
With this page we aim to empower investors researching SRTS by allowing them to research the SRTS market cap history. |
Free SRTS Email Alerts:
Video: The Importance of Market Cap
